Yabing Zheng
- Cancer Research top 10%
- Breast Cancer Treatment Studies 8
- Cancer-related molecular mechanisms research 4
-
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 8
-
- PI3K/AKT/mTOR signaling in cancer 5
- RNA modifications and cancer 4
-
- Advanced Breast Cancer Therapies 14
-
- Estrogen and related hormone effects 6
- Co-authors
- Yu‐An HuangXiying ShaoXiaojia WangZhanhong ChenXingfei YuHongjian YangXiangming HeXianghou Xia
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yabing Zheng
38 papers receiving 421 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 207
- Oncology 143
- Molecular Biology 233
- Pulmonary and Respiratory Medicine 90
- Pathology and Forensic Medicine 35
Countries citing papers authored by Yabing Zheng
This map shows the geographic impact of Yabing Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Zheng more than expected).
Fields of papers citing papers by Yabing Zheng
This network shows the impact of papers produced by Yabing Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Zheng. The network helps show where Yabing Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yabing Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 2 | |
| 5 | PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancerbreakdown → | 2024 | 68 |
| 6 | 2023 | 10 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2019 | 25 | |
| 16 | 2017 | 0 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 7 | |
| 19 | 2016 | 11 | |
| 20 | 2015 | 57 |
About Yabing Zheng
Yabing Zheng is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 425 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (14 papers), HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (207 citations), Oncology (143 citations) and Molecular Biology (233 citations). Yabing Zheng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yu‐An Huang, Xiying Shao, Xiaojia Wang, Zhanhong Chen, Xingfei Yu, Hongjian Yang, Xiangming He, Xianghou Xia, Wen‐Ming Cao and Huanping Zhang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.